CRT Capital initiated coverage on Adamis Pharmaceuticals (NASDAQ: ADMP) with a Buy rating and price target of $15.00.
For an analyst ratings summary and ratings history on Adamis Pharmaceuticals click here. For more ratings news on Adamis Pharmaceuticals click here.
REMARKABLE low number of shares in this stock structure that will make it explode UP!
Where does one find the full research report? What are they basing their $15 PT on?